StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
ResMed, Inc. (RMD) Tops Q3 EPS by 2c
April 25, 2013 5:34 PM
ResMed, Inc. (NYSE: RMD) reported Q3 EPS of $0.58, $0.02 ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Earnings
Next Articles
Goldman Sachs Upgrades ResMed (RMD) to Conviction Buy
April 26, 2013 9:48 AM